Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
1.
Int J Cardiol ; 409: 132212, 2024 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-38806112

RESUMO

BACKGROUND: >40% of infants with Alström Syndrome (AS) present with a transient, severe cardiomyopathy in the first months of life, with apparent recovery in survivors. One in five individuals then develop a later-onset cardiomyopathy but wide clinical variability is observed, even within the same family. The rationale for this study is to provide a comprehensive evaluation of the cardiovascular phenotype in adults with AS. METHODS: Adults attending the National Centre for AS in England were studied. All patients underwent biochemical, 12- lead electrocardiography, echocardiography, and cardiovascular magnetic resonance imaging. RESULTS: 47 adults with AS (64% male; mean age 33 years; 66% white British) were studied. Seven (15%) survived infantile cardiomyopathy and 23 (49%) developed adult-onset cardiomyopathy. Conventional risk factors for cardiovascular disease were present in 39 (83%). Abnormalities were present on biomarkers in 16 (34%), ECG 30 (64%), echocardiography 19 (40%) and CMR 31 (66%). Coronary artery imaging was performed in six (13%), with abnormalities in two. Cardiac, renal, and liver markers were more often impaired in older patients, with impaired left ventricular ejection fraction, reduced global longitudinal strain and late enhancement. 6 (13%) had severe pulmonary hypertension (mean pulmonary artery pressure 46 mmHg) due to left heart disease on invasive testing. CONCLUSION: Cardiomyopathy is common in adults with AS, complicated in a significant proportion by atherosclerotic coronary artery disease and restrictive cardiomyopathy, confirmed on CMR and invasive testing. With advancing age, cardiovascular complications are compounded by contemporaneous renal and liver disease.


Assuntos
Síndrome de Alstrom , Fenótipo , Humanos , Masculino , Feminino , Adulto , Síndrome de Alstrom/complicações , Síndrome de Alstrom/genética , Síndrome de Alstrom/fisiopatologia , Pessoa de Meia-Idade , Adulto Jovem , Adolescente , Eletrocardiografia , Ecocardiografia , Cardiomiopatias/diagnóstico por imagem , Cardiomiopatias/fisiopatologia
2.
Gene ; 727: 144228, 2020 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-31669637

RESUMO

Alström syndrome (AS) is a rare monogenic multi-system ciliopathy disorder with cardinal features, including cone-rod dystrophy, sensory neural hearing loss, metabolic dysfunctions and multiple organ failure caused by bi-allelic mutations in a centrosomal basal body protein-coding gene known as ALMS1. This study aimed to identify pathogenic mutations in a consanguineous Iranian family with AS. Next-generation sequencing was performed on the genomic DNA obtained from a 12 years old girl with AS. According to the bioinformatics analysis, computational modelling and segregation of variants, we identified two homozygous mutations close together in exon 8 of ALMS1 in the patient, including c.7262 G > T and c.7303-7305delAG. The clinically normal parents were heterozygous for both mutations. These mutations have a very rare frequency and only reported in the heterozygous state in the public genomic databases. Overall, due to the large size of the ALMS1 gene and clinical similarity with other ciliopathies and genetic disorders, whole exome sequencing can be useful for the identification of pathogenic mutations and the improvement of AS clinical management.


Assuntos
Síndrome de Alstrom/genética , Proteínas de Ciclo Celular/genética , Adulto , Síndrome de Alstrom/fisiopatologia , Proteínas de Ciclo Celular/metabolismo , Criança , Éxons , Família , Feminino , Perda Auditiva Neurossensorial/genética , Homozigoto , Humanos , Irã (Geográfico) , Masculino , Mutação , Linhagem , Sequenciamento do Exoma/métodos
3.
Hum Mol Genet ; 28(13): 2212-2223, 2019 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-31220269

RESUMO

Alström syndrome (OMIM #203800) is an autosomal recessive obesity ciliopathy caused by loss-of-function mutations in the ALMS1 gene. In addition to multi-organ dysfunction, such as cardiomyopathy, retinal degeneration and renal dysfunction, the disorder is characterized by high rates of obesity, insulin resistance and early-onset type 2 diabetes mellitus (T2DM). To investigate the underlying mechanisms of T2DM phenotypes, we generated a loss-of-function deletion of alms1 in the zebrafish. We demonstrate conservation of hallmark clinical characteristics alongside metabolic syndrome phenotypes, including a propensity for obesity and fatty livers, hyperinsulinemia and glucose response defects. Gene expression changes in ß-cells isolated from alms1-/- mutants revealed changes consistent with insulin hypersecretion and glucose sensing failure, which were corroborated in cultured murine ß-cells lacking Alms1. We also found evidence of defects in peripheral glucose uptake and concomitant hyperinsulinemia in the alms1-/- animals. We propose a model in which hyperinsulinemia is the primary and causative defect underlying generation of T2DM associated with alms1 deficiency. These observations support the alms1 loss-of-function zebrafish mutant as a monogenic model for mechanistic interrogation of T2DM phenotypes.


Assuntos
Síndrome de Alstrom/genética , Diabetes Mellitus Tipo 2/genética , Resistência à Insulina/genética , Insuficiência Renal/genética , Degeneração Retiniana/genética , Peixe-Zebra/genética , Síndrome de Alstrom/fisiopatologia , Animais , Animais Geneticamente Modificados , Linhagem Celular , Modelos Animais de Doenças , Intolerância à Glucose , Hiperinsulinismo/genética , Células Secretoras de Insulina/metabolismo , Camundongos , Modelos Biológicos , Obesidade/genética , Fenótipo , Peixe-Zebra/embriologia
4.
Adv Exp Med Biol ; 1085: 179-180, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30578508

RESUMO

Alström syndrome is an autosomal recessive disease with multisystem involvement, including cone-rod dystrophy, hearing loss, type 2 diabetes, insulin resistance with hyperinsulinemia, dilated cardiomyopathy, and progressive hepatic and renal failure. Patients present in childhood with photophobia and nystagmus, and mimic Leber congenital amaurosis (LCA). The fundus shows pigmentary retinopathy with peau d'orange appearance and some fine white dots like drusen around the macula; the disc is pale, with attenuated retinal vessels (Fig. 35.1). Patients have short stature; boys have hypogonadotropic hypogonadism and girls have polycystic ovary syndrome (PCOS). Obesity is always present, with markedly increased triglyceride and VLDL-C levels; arterial hypertension is diagnosed as early as 2 years of age. There is no polydactyly or syndactyly. About half have developmental delay, but intelligence is usually normal.


Assuntos
Síndrome de Alstrom/fisiopatologia , Criança , Pré-Escolar , Diabetes Mellitus Tipo 2/fisiopatologia , Feminino , Humanos , Masculino , Obesidade/fisiopatologia , Síndrome do Ovário Policístico/fisiopatologia , Retina/patologia , Retinose Pigmentar/fisiopatologia
5.
JCI Insight ; 3(21)2018 11 02.
Artigo em Inglês | MEDLINE | ID: mdl-30385718

RESUMO

Elevated blood pressure (BP) and renal dysfunction are complex traits representing major global health problems. Single nucleotide polymorphisms identified by genome-wide association studies have identified the Alström syndrome 1 (ALMS1) gene locus to render susceptibility for renal dysfunction, hypertension, and chronic kidney disease (CKD). Mutations in the ALMS1 gene in humans causes Alström syndrome, characterized by progressive metabolic alterations including hypertension and CKD. Despite compelling genetic evidence, the underlying biological mechanism by which mutations in the ALMS1 gene lead to the above-mentioned pathophysiology is not understood. We modeled this effect in a KO rat model and showed that ALMS1 genetic deletion leads to hypertension. We demonstrate that the link between ALMS1 and hypertension involves the activation of the renal Na+/K+/2Cl- cotransporter NKCC2, mediated by regulation of its endocytosis. Our findings establish a link between the genetic susceptibility to hypertension, CKD, and the expression of ALMS1 through its role in a salt-reabsorbing tubular segment of the kidney. These data point to ALMS1 as a potentially novel gene involved in BP and renal function regulation.


Assuntos
Síndrome de Alstrom/genética , Hipertensão/metabolismo , Proteínas/genética , Insuficiência Renal Crônica/metabolismo , Síndrome de Alstrom/diagnóstico , Síndrome de Alstrom/fisiopatologia , Animais , Proteínas de Ciclo Celular , Endocitose/fisiologia , Predisposição Genética para Doença , Estudo de Associação Genômica Ampla/métodos , Hipertensão/fisiopatologia , Masculino , Modelos Animais , Mutação , Polimorfismo de Nucleotídeo Único/genética , Transporte Proteico/fisiologia , Ratos , Ratos Sprague-Dawley , Insuficiência Renal Crônica/fisiopatologia , Membro 1 da Família 12 de Carreador de Soluto/metabolismo
6.
Arq. bras. oftalmol ; 81(6): 524-528, Nov.-Dec. 2018. tab, graf
Artigo em Inglês | LILACS | ID: biblio-973855

RESUMO

ABSTRACT Alström syndrome is a rare disorder characterized by mutations to the ALMS1 gene and clinical findings of childhood obesity, diabetes mellitus, dilated cardiomyopathy, sensorineural hearing loss, and progressive cone-rod dystrophy, which may result in blindness. Ocular manifestations occur in the first decade of life with nystagmus, blepharospasm, and photophobia leading to progressive and severe reductions in visual acuity. This study describes the retinal structure and functional aspects of four patients (8 eyes) from two different families as determined by optical coherence tomography (OCT), fundus autofluorescence, and full-field electroretinography. There was a correlation between morphological and functional findings, evidenced by typical funduscopic changes of retinal dystrophy in spectral domain-OCT and electrophysiological analyses. Foveal characteristics include a single layer of undifferentiated photoreceptors with retinal disorganization mainly from external segments, in agreement with previous reports in the literature. Fundus autofluorescence showed areas of hyperautofluorescence interspersed by hypoautofluorescence dots suggesting, respectively, involvement and atrophy of retinal pigmented epithelial cells in the macular zone. Electroretinographic analyses showed early dysfunction of the cones followed by rapid rod deterioration.


RESUMO A síndrome de Alström é uma doença rara caracterizada por mutações no gene AMLS 1 e achados clínicos de obesidade infantil, diabetes mellitus, cardiomiopatia dilatada, surdez neurossensorial e distrofia de cones e bastonetes progressiva, que podem resultar em cegueira. Manifestações oftalmológicas ocorrem na primeira década de vida com nistagmo, blefaroespasmo e fotofobia, levando a reduções progressivas e graves na acuidade visual. Este estudo descreve a estrutura da retina e os aspectos funcionais de quatro pacientes (oito olhos) de duas famílias dis tintas, conforme determinado por tomografia de coerência óptica, autoflourescência de fundo de olho e eletrorretinograma de campo total. Houve correlação entre os achados morfológicos e funcionais evidenciados por alterações fundoscópicas típicas da distrofia retiniana no domínio espectral-OCT e análises eletrofisiológicas. As características foveais incluem uma única camada de fotorreceptores indiferenciados com desorganização retiniana principalmente nos segmentos externos, de acordo com relatos prévios da literatura. A autofluorescência de fundo mostrou áreas de hiperautofluorescência, sugerindo, respectivamente, envolvimento e atrofia das células do epitélio pigmentar da retina na região macular. Análises eletrorretinográficas mostram disfunção precoce de cones, seguida de rápida deteriorização da haste.


Assuntos
Humanos , Masculino , Adolescente , Adulto , Doenças Retinianas/diagnóstico por imagem , Síndrome de Alstrom/diagnóstico por imagem , Doenças Retinianas/fisiopatologia , Acuidade Visual , Saúde da Família , Tomografia de Coerência Óptica , Eletrorretinografia , Síndrome de Alstrom/fisiopatologia , Imagem Óptica , Distrofia de Cones/diagnóstico por imagem
7.
Arq Bras Oftalmol ; 81(6): 524-528, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30328943

RESUMO

Alström syndrome is a rare disorder characterized by mutations to the ALMS1 gene and clinical findings of childhood obesity, diabetes mellitus, dilated cardiomyopathy, sensorineural hearing loss, and progressive cone-rod dystrophy, which may result in blindness. Ocular manifestations occur in the first decade of life with nystagmus, blepharospasm, and photophobia leading to progressive and severe reductions in visual acuity. This study describes the retinal structure and functional aspects of four patients (8 eyes) from two different families as determined by optical coherence tomography (OCT), fundus autofluorescence, and full-field electroretinography. There was a correlation between morphological and functional findings, evidenced by typical funduscopic changes of retinal dystrophy in spectral domain-OCT and electrophysiological analyses. Foveal characteristics include a single layer of undifferentiated photoreceptors with retinal disorganization mainly from external segments, in agreement with previous reports in the literature. Fundus autofluorescence showed areas of hyperautofluorescence interspersed by hypoautofluorescence dots suggesting, respectively, involvement and atrophy of retinal pigmented epithelial cells in the macular zone. Electroretinographic analyses showed early dysfunction of the cones followed by rapid rod deterioration.


Assuntos
Síndrome de Alstrom/diagnóstico por imagem , Doenças Retinianas/diagnóstico por imagem , Adolescente , Adulto , Síndrome de Alstrom/fisiopatologia , Distrofia de Cones/diagnóstico por imagem , Eletrorretinografia , Saúde da Família , Humanos , Masculino , Imagem Óptica , Doenças Retinianas/fisiopatologia , Tomografia de Coerência Óptica , Acuidade Visual
8.
Mol Genet Metab ; 121(4): 336-343, 2017 08.
Artigo em Inglês | MEDLINE | ID: mdl-28610912

RESUMO

BACKGROUND: Alström syndrome (AS) is a rare monogenetic disorder with multi-organ involvement. Complex metabolic disturbances are common and cardiomyopathy is a well-recognized feature in infants as well as in older children and adults. Although the mechanism of cardiomyopathy is not known, previous reports suggest that individuals with infantile-onset cardiac disease recover completely. METHODS: In this single center prospective series of 38 children and adults (age range 1.7 to 37.9years; 20 females) with AS, we evaluated cardiac manifestations in detail, in the context of specific ALMS1 mutations and multisystem involvement. All patients underwent ALMS1 sequencing, biochemical testing, electrocardiogram, and echocardiographic imaging with speckle tracking to evaluate systolic strain; 21 patients underwent cardiac magnetic resonance imaging with T1 mapping. RESULTS: Approximately half of patients (17/38) had a previous diagnosis of cardiomyopathy. Global longitudinal strain, a measure of systolic contractile function, was abnormal in 94% of patients and correlated with body mass index (r=0.602, p=0.002) and C-reactive protein level (r=0.56, p=0.004), but only in children. Electrocardiographic abnormalities were seen in two-thirds of patients, and left ventricular dilatation and/or dysfunction was present in 4 adults and 4 children. CONCLUSION: AS patients with a history of resolved infantile cardiomyopathy continue to have residual impairment in cardiac function. For patients with a normal ejection fraction and no prior cardiac history, strain can be abnormal, suggesting subclinical cardiac involvement. Close cardiac screening and aggressive modification of other manifestations of AS that are risk factors for cardiac disease, including obesity, inflammation, diabetes and dyslipidemia, are essential in caring for patients with AS.


Assuntos
Síndrome de Alstrom/fisiopatologia , Cardiomiopatias/fisiopatologia , Adolescente , Adulto , Síndrome de Alstrom/genética , Proteína C-Reativa/análise , Cardiomiopatias/diagnóstico por imagem , Cardiomiopatias/genética , Proteínas de Ciclo Celular , Criança , Pré-Escolar , Ecocardiografia , Feminino , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Lactente , Imageamento por Ressonância Magnética , Masculino , Estudos Prospectivos , Proteínas/genética , Fatores de Risco , Disfunção Ventricular Esquerda , Adulto Jovem
9.
Am J Med Genet A ; 173(8): 2210-2218, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28573831

RESUMO

Alström syndrome (AS) is a rare autosomal recessive ciliopathy caused by mutations in the ALMS1 gene. Hallmark characteristics include childhood onset of severe retinal degeneration, sensorineural hearing loss, obesity, insulin-resistant diabetes, and cardiomyopathy. Here we comprehensively characterize the auditory and otologic manifestations in a prospective case series of 38 individuals, aged 1.7-37.9 years, with genetically confirmed AS. Hearing loss was preceded by retinal dystrophy in all cases, and had an average age of detection of 7.45 years (range 1.5-15). Audiometric assessments showed mean pure tone averages (0.5, 1, 2, 4 kHz) of 48.6 and 47.5 dB HL in the right and left ears, respectively. Hearing was within normal limits for only 8/74 ears (11%). For the 66 ears with hearing loss, the degree was mild (12%), moderate (54%), or severe (8%). Type of hearing loss was predominantly sensorineural (77%), while three ears had mixed loss, no ears had conductive loss, and type of hearing loss was indeterminate for the remaining 12 ears. Serial audiograms available for 33 patients showed hearing loss progression of approximately 10-15 dB/decade. Our data show that hearing loss associated with AS begins in childhood and is a predominantly symmetric, sensory hearing loss that may progress to a severe degree. Absent otoacoustic emissions, intact speech discrimination, and disproportionately normal auditory brainstem responses suggest an outer hair cell site of lesion. These findings indicate that individuals with AS would benefit from sound amplification and if necessary, cochlear implantation.


Assuntos
Síndrome de Alstrom/fisiopatologia , Cóclea/fisiopatologia , Surdez/fisiopatologia , Perda Auditiva/fisiopatologia , Testes de Impedância Acústica , Adolescente , Adulto , Síndrome de Alstrom/diagnóstico , Síndrome de Alstrom/genética , Audiometria de Tons Puros/métodos , Limiar Auditivo/fisiologia , Proteínas de Ciclo Celular , Criança , Pré-Escolar , Surdez/diagnóstico , Surdez/genética , Técnicas de Diagnóstico Otológico , Feminino , Perda Auditiva/diagnóstico , Perda Auditiva/genética , Humanos , Lactente , Masculino , Proteínas/genética , Adulto Jovem
10.
Am J Med Genet A ; 173(6): 1687-1689, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28407410

RESUMO

Alström Syndrome (AS) is a rare autosomal recessive disorder caused by mutations in the ALMS1 gene. We report monozygotic twin infants who presented concurrently with symptoms of congestive heart failure (CHF) due to dilated cardiomyopathy (DCM). Following their initial presentation, one twin improved both echocardiographically and functionally while the other twin showed a progressive decline in ventricular function and worsening CHF symptoms requiring multiple hospitalizations and augmentation of heart failure therapy. Concordant findings of nystagmus, vision loss, and developmental delay were noted in both twins. Additional discordant findings included obesity and signs of insulin resistance in one twin. Genetic testing on one sibling confirmed AS. These twins underscore the importance of considering AS in any child presenting with DCM, particularly in infancy, and highlights that, even in monozygotic twins, the clinical course of AS is variable with regard to both the cardiac and non-cardiac manifestations of the disease.


Assuntos
Síndrome de Alstrom/fisiopatologia , Cardiomiopatia Dilatada/fisiopatologia , Síndrome de Alstrom/complicações , Síndrome de Alstrom/genética , Síndrome de Alstrom/terapia , Cardiomiopatia Dilatada/complicações , Cardiomiopatia Dilatada/genética , Cardiomiopatia Dilatada/terapia , Proteínas de Ciclo Celular , Ecocardiografia , Feminino , Humanos , Lactente , Masculino , Mutação , Proteínas/genética , Gêmeos Monozigóticos
11.
Artigo em Inglês | MEDLINE | ID: mdl-28096262

RESUMO

The ciliopathies Bardet-Biedl syndrome and Alström syndrome cause obesity. How ciliary dysfunction leads to obesity has remained mysterious, partly because of a lack of understanding of the physiological roles of primary cilia in the organs and pathways involved in the regulation of metabolism and energy homeostasis. Historically, the study of rare monogenetic disorders that present with obesity has informed our molecular understanding of the mechanisms involved in nonsyndromic forms of obesity. Here, we present a framework, based on genetic studies in mice and humans, of the molecular and cellular pathways underlying long-term regulation of energy homeostasis. We focus on recent progress linking these pathways to the function of the primary cilia with a particular emphasis on the roles of neuronal primary cilia in the regulation of satiety.


Assuntos
Síndrome de Alstrom/fisiopatologia , Síndrome de Bardet-Biedl/fisiopatologia , Cílios/fisiologia , Obesidade/patologia , Síndrome de Alstrom/patologia , Animais , Síndrome de Bardet-Biedl/patologia , Metabolismo Energético , Humanos , Camundongos , Obesidade/genética , Resposta de Saciedade
12.
Pediatr Pulmonol ; 52(4): 487-493, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-28029746

RESUMO

OBJECTIVES: Alström syndrome (AS) is a rare, multi-system condition characterized by retinal degeneration, sensorineural hearing loss, obesity, insulin-resistant diabetes, hypertriglyceridemia, cardiomyopathy, hepatorenal disease, and recurrent respiratory infections. It belongs to a group of genetic disorders known as primary ciliopathies, which includes autosomal dominant and recessive polycystic kidney diseases, as well as Joubert and Bardet-Biedl syndromes. Prior studies have suggested phenotypic overlap between primary ciliopathies affecting the non-motile, sensory cilia, and primary ciliary dyskinesia (PCD), a motile ciliopathy characterized by respiratory tract disease. METHODS: We describe the burden of oto-sino-pulmonary disease in 38 individuals with AS and examines the degree of clinical overlap between PCD and AS. Evaluation at the NIH Clinical Center included clinical examination, chest imaging, and clinical history surveys, as well as measurement of nasal nitric oxide (nNO) in nine patients. RESULTS: Recurrent otitis media was ubiquitous in the AS cohort (92%) with 50% requiring pressure equalization tube placement. A history of bronchitis/pneumonia and sinusitis was reported in 61% and 50% of individuals, respectively. PCD-characterizing symptoms (laterality defects, unexplained neonatal respiratory distress, year-round nasal congestion, and wet cough) were far less prevalent in the AS cohort compared to PCD, and the average nNO production in the AS cohort was 232 ± 57.1 nl/min compared to a cut-off of <77 nl/min for PCD. CONCLUSIONS: These data suggest that the oto-sino-respiratory complications in AS are prominent enough to warrant increased clinical attention, but significantly impaired respiratory cilia function as seen in PCD is unlikely in AS. (www.clinicaltrials.gov, trial NCT00068224) Pediatr Pulmonol. 2017;52:487-493. © 2016 Wiley Periodicals, Inc.


Assuntos
Síndrome de Alstrom/diagnóstico , Adolescente , Adulto , Fatores Etários , Síndrome de Alstrom/fisiopatologia , Criança , Pré-Escolar , Transtornos da Motilidade Ciliar/fisiopatologia , Tosse/fisiopatologia , Diagnóstico Diferencial , Feminino , Humanos , Lactente , Masculino , National Institutes of Health (U.S.) , Prevalência , Índice de Gravidade de Doença , Estados Unidos
13.
Middle East Afr J Ophthalmol ; 23(1): 139-41, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26957854

RESUMO

UNLABELLED: To report novel mutations in two Saudi children with clinical features of Leber congenital amaurosis (LCA) and Alström syndrome. CASE REPORTS: Case 1 was a child with phenotypic features of LCA including oculodigital sign, bilateral enophthalmos, nystagmus, pale disc, and retinal changes. Direct sequencing of the coding sequence of GUCY2D revealed a missense mutation affecting highly conserved position (c. 743C > T; p.S248 L). Case 2 describes a girl with marked nystagmus, photophobia, and retinal changes in both eyes with short and stubby fingers tapering at the distal phalanges. The electroretinograms were nonrecordable in each eye. She had a hearing aid in the left ear, mid-facial hypoplasia, bilateral enophthalmos, and insulin dependent diabetes. Mutation screening of candidates genes revealed a pathogenic mutation in ALMS1 gene (c. 8441C > A, p.S2814). Two novel mutations causing phenotypic LCA and Alström syndrome in Saudi patients from consanguineous families expand the genotypic spectrum of congenital retinal dystrophies.


Assuntos
Síndrome de Alstrom/genética , Guanilato Ciclase/genética , Amaurose Congênita de Leber/genética , Mutação de Sentido Incorreto , Proteínas/genética , Receptores de Superfície Celular/genética , Retina/fisiologia , Distrofias Retinianas/genética , Síndrome de Alstrom/diagnóstico , Síndrome de Alstrom/fisiopatologia , Proteínas de Ciclo Celular , Criança , Consanguinidade , Análise Mutacional de DNA , Eletrorretinografia , Feminino , Humanos , Lactente , Amaurose Congênita de Leber/diagnóstico , Amaurose Congênita de Leber/fisiopatologia , Linhagem , Distrofias Retinianas/diagnóstico , Distrofias Retinianas/fisiopatologia , Arábia Saudita
14.
Orphanet J Rare Dis ; 10: 83, 2015 Jun 24.
Artigo em Inglês | MEDLINE | ID: mdl-26104972

RESUMO

BACKGROUND: Alström syndrome is a rare inherited ciliopathy with progressive multisystem involvement. Dilated cardiomyopathy is common in infancy and recurs or presents de novo in adults with high rates of premature cardiovascular death. Although Alström syndrome is characterised by fibrosis in solid organs such as the liver, the pathogenesis of related cardiomyopathy are not clear. To date it is not known whether diffuse interstitial myocardial fibrosis is present before the onset of heart failure symptoms or changes in conventional parameters of left ventricular function. METHODS: In this observational study, 26 patients with Alström syndrome (mean age 27 ± 9 years, 65 % male, 24 h ABPM 130 ± 14 / 77 ± 9 mmHg) without symptomatic cardiovascular disease were recruited from a single centre and compared to matched healthy controls. All subjects underwent cardiac MRI (1.5 T) to assess ventricular function, diffuse interstitial myocardial fibrosis by measurement of extracellular volume on T1-mapping (MOLLI) and coarse replacement fibrosis using standard late gadolinium enhancement imaging. RESULTS: Global extracellular volume was increased in Alström syndrome with wider variation compared to controls (0.30 ± 0.05 vs. 0.25 ± 0.01, p < 0.05). Left ventricular long axis function and global longitudinal strain were impaired in Alström syndrome without change in ejection fraction, ventricular size or atrial stress (NT-proBNP) (p < 0.05). Global extracellular volume was associated with reduced peak systolic longitudinal strain (r = -0.73, p < 0.01) and strain rate (r = -0.57, p < 0.01), increased QTc interval (r = 0.49, p < 0.05) and serum triglycerides (r = 0.66, p < 0.01). Nine (35 %) patients had diffuse mid-wall late gadolinium enhancement in a non-coronary artery distribution. CONCLUSION: Diffuse interstitial myocardial fibrosis is common in Alström syndrome and is associated with impaired left ventricular systolic function. Serial studies are required to determine whether global extracellular volume may be an independent imaging biomarker of vulnerability to dilated cardiomyopathy and heart failure.


Assuntos
Síndrome de Alstrom/patologia , Cardiomiopatias/patologia , Ventrículos do Coração/patologia , Adolescente , Adulto , Síndrome de Alstrom/fisiopatologia , Cardiomiopatias/fisiopatologia , Feminino , Ventrículos do Coração/fisiopatologia , Humanos , Imageamento por Ressonância Magnética , Masculino , Função Ventricular Esquerda/fisiologia , Adulto Jovem
15.
J Clin Endocrinol Metab ; 100(8): E1116-24, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26066530

RESUMO

CONTEXT: Alström syndrome is characterized by increased risk of cardiovascular disease from childhood. OBJECTIVE: To explore the association between risk factors for cardiovascular disease, aortic pulse wave velocity, and vascular events in Alström syndrome. DESIGN: Cross-sectional analyses with 5-year follow-up. SETTING: The UK NHS nationally commissioned specialist clinics for Alström syndrome. PATIENTS: Thirty-one Alström patients undertook vascular risk assessment, cardiac studies, and aortic pulse wave velocity measurement. Subsequent clinical outcomes were recorded. INTERVENTIONS: Insulin resistance was treated with lifestyle intervention and metformin, and diabetes with the addition of glitazones, glucagon-like peptide 1 agonists, and/or insulin. Thyroid and T deficiencies were corrected. Dyslipidemia was treated with statins and nicotinic acid derivatives. Cardiomyopathy was treated with standard therapy as required. MAIN OUTCOME MEASURES: The associations of age, gender, and risk factors for cardiovascular disease with aortic pulse wave velocity were assessed and correlated with the effects of reduction in left ventricular function. Vascular events were monitored for 5 years. RESULTS: Aortic pulse wave velocity was positively associated with the duration of diabetes (P = .001) and inversely with left ventricular ejection fraction (P = .036). Five of the cohort with cardiovascular events had higher aortic pulse wave velocity (P = .0247), and all had long duration of diabetes. CONCLUSIONS: Duration of diabetes predicted aortic pulse wave velocity in Alström syndrome, which in turn predicted cardiovascular events. This offers hope of secondary prevention because type 2 diabetes can be delayed or reversed by lifestyle interventions.


Assuntos
Síndrome de Alstrom/complicações , Síndrome de Alstrom/fisiopatologia , Doenças Cardiovasculares/diagnóstico , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/fisiopatologia , Análise de Onda de Pulso , Adolescente , Adulto , Síndrome de Alstrom/diagnóstico , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/fisiopatologia , Criança , Estudos Transversais , Diabetes Mellitus Tipo 2/diagnóstico , Feminino , Seguimentos , Humanos , Masculino , Prognóstico , Fatores de Tempo , Adulto Jovem
16.
Audiol Neurootol ; 20(4): 267-72, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26111748

RESUMO

Alström's syndrome is an autosomal recessive syndromic genetic disorder caused by mutations in the ALMS1 gene. Sensorineural hearing loss occurs in greater than 85% of patients. Histopathology of the inner ear abnormalities in the human has not previously been fully described. Histopathology of the inner ear in Alström's syndrome is presented in 2 genetically confirmed cases. The predominant histopathologic correlates of the sensorineural loss were degeneration of the organ of Corti, both inner and outer hair cells, degeneration of spiral ganglion cells, and atrophy of the stria vascularis and spiral ligament.


Assuntos
Síndrome de Alstrom/patologia , Orelha Interna/patologia , Perda Auditiva Neurossensorial/patologia , Adulto , Síndrome de Alstrom/complicações , Síndrome de Alstrom/fisiopatologia , Audiometria de Tons Puros , Orelha Interna/fisiopatologia , Potenciais Evocados Auditivos do Tronco Encefálico , Feminino , Células Ciliadas Auditivas Internas/patologia , Células Ciliadas Auditivas Externas/patologia , Perda Auditiva Neurossensorial/etiologia , Perda Auditiva Neurossensorial/fisiopatologia , Humanos , Masculino , Órgão Espiral/patologia , Gânglio Espiral da Cóclea/patologia , Ligamento Espiral da Cóclea/patologia , Estria Vascular/patologia
17.
Braz J Otorhinolaryngol ; 80(2): 99-104, 2014 04.
Artigo em Inglês, Português | MEDLINE | ID: mdl-24830966

RESUMO

INTRODUCTION: Alström Syndrome is a rare disease caused by mutations in ALMS1 gene. It is characterized by a progressive degeneration of sensory functions, resulting in visual and audiological impairment, as well as metabolic disturbances such as childhood obesity, hyperinsulinemia, and diabetes mellitus type 2. OBJECTIVE: To report and discuss the genetic and audiological findings in two siblings with Alström syndrome. METHODS: This was a prospective, analytical and descriptive study, using questionnaires, serial audiograms, otoacoustic emissions, and auditory brainstem response analysis, as well as molecular genetic analysis. RESULTS: Both patients presented childhood-onset bilateral sensorineural hearing loss, which progressed to moderate impairment in the first case and severe hearing loss in the second. Otoacoustic emissions were absent, and auditory brainstem responses were bilaterally normal in both cases. CONCLUSION: In the present patients, Alström Syndrome began with a neurosensory hearing loss in early childhood that progressed to a profound loss in ten to twenty years. The auditory lesions were cochlear in origen according to the otoacoustic emissions and auditory brainstem responses.


Assuntos
Síndrome de Alstrom/complicações , Potenciais Evocados Auditivos do Tronco Encefálico/fisiologia , Perda Auditiva Bilateral/etiologia , Perda Auditiva Neurossensorial/etiologia , Emissões Otoacústicas Espontâneas/fisiologia , Testes de Impedância Acústica , Adulto , Síndrome de Alstrom/genética , Síndrome de Alstrom/fisiopatologia , Audiometria de Tons Puros , Perda Auditiva Bilateral/fisiopatologia , Perda Auditiva Neurossensorial/fisiopatologia , Humanos , Masculino , Linhagem , Estudos Prospectivos
18.
Braz. j. otorhinolaryngol. (Impr.) ; 80(2): 99-104, Mar-Apr/2014. graf
Artigo em Português | LILACS | ID: lil-709510

RESUMO

Introdução: A Síndrome de Alstrom é uma doença muito rara, causada pela mutação no gene Obesidade infantil; ALMS1, que apresenta uma degeneração progressiva das funções sensoriais, resultando em de-Diabetes mellitus tipo 2; ficiências visuais e auditivas, além de distúrbios metabólicos como obesidade na infância, hipe-Retinite pigmentosa rinsulinemia e diabetes tipo II. Objetivo: Apresentar o perfil audiométrico de dois irmãos da mesma família afetados pela Síndrome de Alström. Método: Estudo prospectivo, analítico descritivo, os pacientes afetados foram submetidos a um questionário previamente testado, audiometria tonal e vocal seriadas, análise de emissões otoacústicas, e de respostas de potencial evocado auditivo de tronco encefálico, além de análise genético-molecular para comprovação diagnóstica. Resultados: Ambos os pacientes apresentaram perda auditiva bilateral com o início na infância e progressão lenta para perda auditiva neurosensorial severa no primeiro caso e, profunda, no segundo. As emissões otoacústicas estavam ausentes, e o potencial evocado auditivo de tronco encefálico estava normal em ambos os pacientes, bilateralmente. Conclusão: A Síndrome de Alström apresenta início precoce de perda auditiva neurossensorial, antes da adolescência, 10 a 20 anos para desenvolver perda auditiva severa a profunda. A lesão auditiva é essencialmente coclear, de acordo com os resultados dos testes de emissões otoacústicas e de potenciais evocados auditivos de tronco encefálico. .


Introduction: Alström Syndrome is a rare disease caused by mutations in ALMS1 gene. It is characterized by a progressive degeneration of sensory functions, resulting in visual and audiological impairment, as well as metabolic disturbances such as childhood obesity, hyperinsulinemia, and diabetes mellitus type 2. Objective: To report and discuss the genetic and audiological findings in two siblings with Alström syndrome. Methods: This was a prospective, analytical and descriptive study, using questionnaires, serial audiograms, otoacoustic emissions, and auditory brainstem response analysis, as well as molecular genetic analysis. Results: Both patients presented childhood-onset bilateral sensorineural hearing loss, which progressed to moderate impairment in the first case and severe hearing loss in the second. Otoacoustic emissions were absent, and auditory brainstem responses were bilaterally normal in both cases. Conclusion: In the present patients, Alström Syndrome began with a neurosensory hearing loss in early childhood that progressed to a profound loss in ten to twenty years. The auditory lesions were cochlear in origen according to the otoacoustic emissions and auditory brainstem responses. .


Assuntos
Adulto , Humanos , Masculino , Síndrome de Alstrom/complicações , Potenciais Evocados Auditivos do Tronco Encefálico/fisiologia , Perda Auditiva Bilateral/etiologia , Perda Auditiva Neurossensorial/etiologia , Emissões Otoacústicas Espontâneas/fisiologia , Testes de Impedância Acústica , Audiometria de Tons Puros , Síndrome de Alstrom/genética , Síndrome de Alstrom/fisiopatologia , Perda Auditiva Bilateral/fisiopatologia , Perda Auditiva Neurossensorial/fisiopatologia , Linhagem , Estudos Prospectivos
19.
Clin Endocrinol (Oxf) ; 79(4): 529-36, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23445176

RESUMO

INTRODUCTION: Alström syndrome (ALMS) is a rare autosomal recessive monogenic disease included in an emerging class of genetic disorders called 'ciliopathies' and is likely to impact the central nervous system as well as metabolic and endocrine function. Individuals with ALMS present clinical features resembling a growth hormone deficiency (GHD) condition, but thus far no study has specifically investigated this aspect in a large population. MATERIAL AND METHODS: Twenty-three patients with ALMS (age, 1-52 years; 11 males, 12 females) were evaluated for anthropometric parameters (growth charts and standard deviation score (SDS) of height, weight, BMI), GH secretion by growth hormone-releasing hormone + arginine test (GHRH-arg), bone age, and hypothalamic-pituitary magnetic resonance imaging (MRI). A group of 17 healthy subjects served as controls in the GH secretion study. Longitudinal retrospective and prospective data were utilized. RESULTS: The length-for-age measurements from birth to 36 months showed normal growth with most values falling within -0·67 SDS to +1·28 SDS. A progressive decrease in stature-for-age was observed after 10 years of age, with a low final height in almost all ALMS subjects (>16-20 years; mean SDS, -2·22 ± 1·16). The subset of 12 patients with ALMS tested for GHRH-arg showed a significantly shorter stature than age-matched controls (154·7 ± 10·6 cm vs 162·9 ± 4·8 cm, P = 0·009) and a mild increase in BMI (Kg/m(2) ) (27·8 ± 4·8 vs 24·1 ± 2·5, P = 0·007). Peak GH after GHRH-arg was significantly lower in patients with ALMS in comparison with controls (11·9 ± 6·9 µg/l vs 86·1 ± 33·2 µg/l, P < 0·0001). Severe GHD was evident biochemically in 50% of patients with ALMS. The 10 adult ALMS patients with GHD showed a reduced height in comparison with those without GHD (149·7 ± 6·2 cm vs 161·9 ± 9·2 cm, P = 0·04). MRIs of the diencephalic and pituitary regions were normal in 11 of 12 patients. Bone age was advanced in 43% of cases. CONCLUSIONS: Our study shows that 50% of nonobese ALMS patients have an inadequate GH reserve to GHRH-arg and may be functionally GH deficient. The short stature reported in ALMS may be at least partially influenced by impairment of GH secretion.


Assuntos
Síndrome de Alstrom/metabolismo , Estatura , Peso Corporal , Transtornos do Crescimento/metabolismo , Hormônio do Crescimento/deficiência , Adolescente , Adulto , Síndrome de Alstrom/genética , Síndrome de Alstrom/fisiopatologia , Índice de Massa Corporal , Proteínas de Ciclo Celular , Criança , Pré-Escolar , Diencéfalo/diagnóstico por imagem , Diencéfalo/patologia , Feminino , Transtornos do Crescimento/genética , Transtornos do Crescimento/fisiopatologia , Hormônio do Crescimento/metabolismo , Humanos , Lactente , Estudos Longitudinais , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Mutação , Hipófise/diagnóstico por imagem , Hipófise/patologia , Proteínas/genética , Radiografia , Estudos Retrospectivos , Adulto Jovem
20.
Orphanet J Rare Dis ; 8: 24, 2013 Feb 13.
Artigo em Inglês | MEDLINE | ID: mdl-23406482

RESUMO

BACKGROUND: Alström Syndrome (AS) is a rare ciliopathy characterized by cone-rod retinal dystrophy, sensorineural hearing loss, obesity, type 2 diabetes mellitus and cardiomyopathy. Most patients do not present with neurological issues and demonstrate normal intelligence, although delayed psychomotor development and psychiatric disorders have been reported. To date, brain Magnetic Resonance Imaging (MRI) abnormalities in AS have not been explored. METHODS: We investigated structural brain changes in 12 genetically proven AS patients (mean-age 22 years; range: 6-45, 6 females) and 19 matched healthy and positive controls (mean-age 23 years; range: 6-43; 12 females) using conventional MRI, Voxel-Based Morphometry (VBM) and Diffusion Tensor Imaging (DTI). RESULTS: 6/12 AS patients presented with brain abnormalities such as ventricular enlargement (4/12), periventricular white matter abnormalities (3/12) and lacune-like lesions (1/12); all patients older than 30 years had vascular-like lesions. VBM detected grey and white matter volume reduction in AS patients, especially in the posterior regions. DTI revealed significant fractional anisotropy decrease and radial diffusivity increase in the supratentorial white matter, also diffusely involving those regions that appeared normal on conventional imaging. On the contrary, axial and mean diffusivity did not differ from controls except in the fornix. CONCLUSIONS: Brain involvement in Alström syndrome is not uncommon. Early vascular-like lesions, gray and white matter atrophy, mostly involving the posterior regions, and diffuse supratentorial white matter derangement suggest a role of cilia in endothelial cell and oligodendrocyte function.


Assuntos
Síndrome de Alstrom/fisiopatologia , Encéfalo/fisiopatologia , Adolescente , Adulto , Idoso , Criança , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...